155 related articles for article (PubMed ID: 2524119)
1. Does acute experimental pancreatitis affect blood platelet function?
Lukaszyk A; Bodzenta-Lukaszyk A; Gabryelewicz A; Bielawiec M
Thromb Res; 1989 Feb; 53(3):319-25. PubMed ID: 2524119
[TBL] [Abstract][Full Text] [Related]
2. Blood platelet function in canine acute pancreatitis with reference to treatment with Nafamostat mesilate (FUT-175).
Lukaszyk A; Bodzenta-Lukaszyk A; Gabryelewicz A; Bielawiec M
Thromb Res; 1992 Jan; 65(2):229-39. PubMed ID: 1579898
[TBL] [Abstract][Full Text] [Related]
3. Platelet function in experimentally induced pancreatitis in the dog.
Jacobs RM; Murtaugh RJ; Fertel RH
Thromb Haemost; 1986 Apr; 55(2):197-200. PubMed ID: 3087002
[TBL] [Abstract][Full Text] [Related]
4. Effect of FUT-175 (nafamstat mesilate) on platelets in canine acute experimental pancreatitis.
Gabryelewicz A; Prokopowicz J; Bodzenta A; Bielecki W; Rydzewska G
Digestion; 1988; 40(1):19-24. PubMed ID: 3234615
[TBL] [Abstract][Full Text] [Related]
5. Platelet aggregation in the Asian elephant is not dependent on thromboxane B2 production.
Gentry PA; Niemuller C; Ross ML; Liptrap RM
Comp Biochem Physiol A Comp Physiol; 1989; 94(1):47-51. PubMed ID: 2571453
[TBL] [Abstract][Full Text] [Related]
6. Synergistic effects of platelet-activating factor and other platelet agonists in human platelet aggregation and release: the role of ADP and products of the cyclooxygenase pathway.
Sturk A; Asyee GM; Schaap MC; van Maanen M; ten Cate JW
Thromb Res; 1985 Nov; 40(3):359-72. PubMed ID: 2934863
[TBL] [Abstract][Full Text] [Related]
7. Enhanced platelet release reaction and increased thromboxane generation in esophageal achalasia and selective in vitro inhibition of arachidonic acid induced platelet aggregation by vasoactive intestinal peptide.
Zahavi M; Rozen P; Zahavi J
Thromb Res; 1990 Aug; 59(3):693-9. PubMed ID: 2146767
[No Abstract] [Full Text] [Related]
8. Stimulated platelet aggregation, thromboxane B2 formation and platelet sensitivity to prostacyclin - a critical evaluation.
Siess W; Roth P; Weber PC
Thromb Haemost; 1981 Jun; 45(3):204-7. PubMed ID: 7025338
[TBL] [Abstract][Full Text] [Related]
9. Adrenaline infusion evokes increased thromboxane B2 production by platelets in healthy men: the effect of beta-adrenoceptor blockade.
Laustiola K; Kaukinen S; Seppälä E; Jokela T; Vapaatalo H
Eur J Clin Invest; 1986 Dec; 16(6):473-9. PubMed ID: 2881786
[TBL] [Abstract][Full Text] [Related]
10. Enhanced platelet release reaction, shortened platelet survival time and increased platelet aggregation and plasma thromboxane B2 in chronic obstructive arterial disease.
Zahavi J; Zahavi M
Thromb Haemost; 1985 Feb; 53(1):105-9. PubMed ID: 3158092
[TBL] [Abstract][Full Text] [Related]
11. Combined arachidonic acid and ADP platelet inhibition maximizes patency of small-diameter vascular grafts.
Valentin LI; Sicard GA; Freeman MB; Allen BT; McGoff MA; Anderson CB
Surgery; 1988 Aug; 104(2):178-84. PubMed ID: 3135624
[TBL] [Abstract][Full Text] [Related]
12. Studies on the stimulation of human blood platelets by semi-synthetic platelet-activating factor.
Ostermann G; Till U; Thielmann K
Thromb Res; 1983 Apr; 30(2):127-36. PubMed ID: 6408754
[TBL] [Abstract][Full Text] [Related]
13. Platelet activating factor (PAF) causes human platelet aggregation through the mechanism of membrane modulation.
Rao GH; White JG
Prostaglandins Leukot Med; 1982 Oct; 9(4):459-72. PubMed ID: 6817343
[TBL] [Abstract][Full Text] [Related]
14. Influence of phentolamine on platelet aggregation, thromboxane B2 production and release reaction.
Anfossi G; Trovati M; Mularoni E; Lanzio M; Massucco P; Emanuelli G
Arch Int Pharmacodyn Ther; 1988; 296():144-54. PubMed ID: 2853612
[TBL] [Abstract][Full Text] [Related]
15. Possible participation of adenosine 5'-diphosphate, arachidonic acid and paf-acether in the platelet pro-aggregating effect of uncontrolled insulin-dependent diabetic erythrocytes in vitro.
Juhan-Vague I; Chignard M; Poisson C; Roul C; Billerey M; Buonocore M; Driss F; Vague P; Benveniste J
Thromb Res; 1985 Apr; 38(1):83-9. PubMed ID: 3923649
[TBL] [Abstract][Full Text] [Related]
16. Specific inhibition of PAF-acether-induced platelet activation by BN 52021 and comparison with the PAF-acether inhibitors kadsurenone and CV 3988.
Nunez D; Chignard M; Korth R; Le Couedic JP; Norel X; Spinnewyn B; Braquet P; Benveniste J
Eur J Pharmacol; 1986 Apr; 123(2):197-205. PubMed ID: 3086108
[TBL] [Abstract][Full Text] [Related]
17. Platelet function in platelet concentrates and in whole blood.
Rodgers SE; Lloyd JV; Russell WJ
Anaesth Intensive Care; 1985 Nov; 13(4):355-61. PubMed ID: 2934002
[TBL] [Abstract][Full Text] [Related]
18. Acquisition and aggregation of canine blood platelets: basic mechanisms of function and differences because of breed origin.
Clemmons RM; Meyers KM
Am J Vet Res; 1984 Jan; 45(1):137-44. PubMed ID: 6422804
[TBL] [Abstract][Full Text] [Related]
19. The influence of fenflumizole on platelet aggregation in patients with unstable angina pectoris.
Grauholt AM; Grande P; Wadt J
Eur J Clin Pharmacol; 1987; 31(5):547-51. PubMed ID: 2951260
[TBL] [Abstract][Full Text] [Related]
20. Role of thromboxane A2.
Ambler J; Birch J; Maguire ED; Wallis RB
Adv Exp Med Biol; 1985; 192():293-308. PubMed ID: 2939695
[No Abstract] [Full Text] [Related]
[Next] [New Search]
